Abstract
The cytochrome P450 (CYP) enzymes metabolize drugs and other xenobiotics in liver and also in some extrahepatic tissues. We have studied the expression and localization of CYP3A in primary lung tumours and normal lung tissue from the same patients. Thirtytwo patients undergoing partial or total lung resection for therapy of primary pulmonary carcinoma were included in this study. Immunohistochemical staining for CYP3A was performed with a modification of the ABC technique. Eight of the 32 cases of primary pulmonary carcinoma showed expression of CYP3A. In 12 of the 32 cases of normal tissue, the seromucous glands were positive for CYP3A. The bronchial epithelium was positive for CYP3A in 11 cases. We observed no correlation between CYP3A expression in tumour tissue and that in seromucous glands or bronchial epithelium. We conclude that CYP3A is present in both normal and cancerous lung tissue. Our findings suggest, however, no co-expression of CYP3A in lung cancer.
Similar content being viewed by others
References
Bend JR, Serabjit-Singh CJ, Philpot RM (1985) The pulmonary uptake, accumulation, and metabolism of xenobiotics. Annu Rev Pharmacol Toxicol 25:97–125
Chang TKH, Weber GF, Crespi CL, Waxman DJ (1993) Differential activation of cyclophosphamide and ifosphamide by cytochromes P-450 2B and 3A in human liver microsomes. Cancer Res 53:5629–5637
Cohen GM, Gibby EM, Mehta R (1981) Routes of conjugation in normal and cancerous tissue from human lung. Nature 291:662–664
Dechant KL, Brogden RN, Pilkington T, Faulds D (1991) Ifosfamide/mesna: a review of its antineoplastic activity, pharmacokinetic properties and therapeutic efficacy in cancer. Drugs 42:428–467
Fritz P, Mueller J, Wegner G, Braun U, Grau A, Tuczek HV, Moessner E, Schenk R (1985) Immunohistochemie: theoretische Möglichkeiten, praktische Anwendungen. Zentralbl Allg Pathol Anat 30:187–193
Fritz P, Behrle E, Beaune P, Eichelbaum M, Kroemer HK (1993) Differential expression of drug metabolizing enzymes in primary and secondary liver neoplasm: immunohistochemical characterization of cytochrome P450 3A and glutathione-S-transferase. Histochemistry 99:443–451
Gonzalez FJ (1992) Human cytochromes P450: problems and prospects. Trends Pharmacol Sci 13:346–352
Gonzalez FJ, Idle JR (1994) Pharmacogenetic phenotyping and genotyping: present status and future potential. Clin Pharmacokinet 26:59–70
Guengerich FP (1993) Bioactivation and detoxication of toxic and carcinogenic chemicals. Drug Metab Dispos 21:1–6
Guengerich FP, Martin MV, Beaune PH, Kremers P, Wolff T, Waxman DJ (1986) Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genomic polymorphism in oxidative drug metabolism. J Biol Chem 261:5051–5060
Hsu SM, Raine L, Fanger H (1981) The use of anti-avidin antibody and avidin-biotin-complex in immunoperoxidase techniques. Am J Clin Pathol 75:816–821
Kikkawa Y (1992) Diverse role of pulmonary cytochrome P-450 monooxygenase. Lab Invest 67:535–539
Krishna DR, Klotz U (1994) Extrahepatic metabolism of drugs in humans. Clin Pharmacokinet 26:144–160
McLemore TL, Adelberg S, Liu MC, McMahon NA, Yu SJ, Hubbard WC, Czerwinski M, Wood TG, Storeng R, Lubet RA, Eggleston JC, Boyd MR, Hines RN (1990) Expression of CYP1A1 gene in patients with lung cancer: evidence for cigarette smoke-induced gene expression in normal lung tissue and for altered gene regulation in primary pulmonary carcinomas. J Natl Cancer Inst 82:1333–1339
Murray GI, Barnes TS, Sewell HF, Ewen SWB, Melvin WT, Burke MD (1988) The immunocytochemical localisation and distribution of cytochrome P-450 in normal human hepatic and extrahepatic tissues with a monoclonal antibody to human cytochrome P-450. Br J Clin Pharmacol 25:465–475
Toussaint C, Albin N, Massaad L, Grunenwald D, Parise O, Morizet J, Gouyette A, Chabot GG (1993) Main drug- and carcinogen-metabolizing enzyme systems in human non-small cell lung cancer and peritumoral tissues. Cancer Res 53:4608–4612
Voigt JM, Kawabatta TT, Burke JP, Martin MV, Guengerich FP, Baron J (1990) In situ localization and distribution of xenobiotic-activating enzymes and aryl hydrocarbon hydroxylase activity in lungs of untreated rats. Mol Pharmacol 37:182–191
Wheeler CW, Wrighton SA, Guenthner TM (1992) Detection of human lung cytochromes P450 that are immunochemically related to cytochrome P450IIE1 and cytochrome P450IIIA. Biochem Pharmacol 44:183–186
Wössner R, Toomes H, Fritz P, Linder A, Dierkesmann RE, Behrle E, Wicherek C (1994) Immunohistochemical demonstration of glycoprotein 170 and glutathione S-transferase isoenzymes in normal and neoplastic bronchial tissue. Onkologie 17:28–34
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kivistö, K.T., Kroemer, H.K., Fritz, P. et al. Immunohistochemical localization of cytochrome P450 3A in human pulmonary carcinomas and normal bronchial tissue. Histochem Cell Biol 103, 25–29 (1995). https://doi.org/10.1007/BF01464472
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01464472